NSI-189
Cas No: 1270138-40-3
MF: C22H30N4O
MW: 366.4998
Assay:98%
Appearance: white powder
Used:
Treatment of major depressive disorder.
How NSI-189 works ?
This drug was developed to address three important aspects of depression including hippocampal volume, neurogenesis and neurotransmission. NSI-189 increases the volume within the hippocampus. In so doing, hippocampal volume and healthy brain cell density is increased thereby improving mod and cognitive performance. Aside from increasing hippocampal volume, the drug also improves neuronal cell functionality. It works it promoting healthy neuronal cell growth whilst repair damaged areas in the brain.
Dosage and Suggestion:
Studies conducted to evaluate effects of NSI-189 revealed that 40 to 80 mg daily is effective in treating depression and cognitive symptoms amongst healthy patients. In these trials, there are no serious adverse events recorded. Generally, NSI-189 is well tolerated and safe for human use.
Specifications: COA
Test Item |
Specification |
Result |
Appearance |
White powder |
Conforms |
HNMR |
Conforms to structure |
Conforms |
LCMS |
Conforms to MW |
Conforms |
Assay |
≥99.0% |
99.20% |
Storage: Store in well-closed container,protected from light. Conclusion: This product complies with above specification. |